Baiyunshan Pharma Rises on Share Sale to Jack Ma-Linked Fund

Guangzhou Baiyunshan Pharmaceutical Holdings Co. surged in Hong Kong trading on plans to raise as much as 10 billion yuan ($1.6 billion) by selling shares to investors including a private equity firm co-founded by Alibaba Group Holding Ltd. Chairman Jack Ma.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.